FDA
-
-
-
-
-
-
-
Alpha Tau completes enrollment in pivotal skin cancer trial
-
-
-
-
-
-
-
Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Alpha Tau Medical (DRTS) Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT for Patients with Recurrent Glioblastoma Multiforme
-
-
-
-
-
-
-
Alpha Tau Medical Announces Second Quarter 2022 Financial Results and Provides Corporate Update
-
-
-
-
322,134 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

